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1. Introduction
Nootropics belong to a class of psychotropic
agents with selective facilitatory effect on the
cognitive functions of CNS such as  intellectual
performance, learning and memory [1]. There
are extensive reports on the nootropic
compounds of plant origin such as Celestrus
paniculatus [2], Baccopa monniera [3],
Centella asiatica [4] and Lawsonia inermis
[5].The roots of Moringa oleifera (Lam.
Moringaceae) are bitter, acrid thermogenic,
digestive, carminative, anthelmintic,
constipating, anodyne, anti-inflammatory. The
bark has antifungal and abortificient effects.
The leaves are anti-inflammatory, anodyne,
anthelmintic ophthalmic and rich in Vitamin
A and Vitamin C. Seeds are useful in neuralgia,
inflammations, intermittent fever and
ophthalmology [6]. It also has antioxidant [7],
hypotensive [8] and hepatoprotective effects [9].
However, reports on its neuropharma-cological
studies are scanty. Therefore, the present study
is aimed at exploring the nootropic effect of
Moringa oleifera  leaves.
2. Materials and methods
2.1 Preparation of extract
Shade dried leaves (0.5 kg) of  Moringa oleifera
(Moringaceae) collected locally was
authenticated and defatted with petroleum
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Abstract
Objective:  To study the nootropic activity of leaves of Moringa oleifera.  Methods:  Toluene–ethylacetate
fraction of methanolic extract of Moringa oleifera  (MOE) leaves was assessed for its nootropic activity
using passive shock avoidance paradigm and elevated plus maze. MOE ( 50 and 100 mg/kg ) was compared
with Piracetam (100 mg/kg ). Scopolamine (1 mg/kg) was used  to induce cognitive dysfunction. The
extract was also studied for its effect on gross behaviour. Results: MOE (50 and 100 mg/kg ) significantly
decreased Transfer Latency(TL) on Day 2. The extract reduced the latency to reach the SFZ and the
number of mistakes. No adverse effects were observed upto a dose of 200 mg/kg. Conclusion: Thus the
leaves of Moringa oleifera  possess a potential for exploring the nootropic principle.
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ether (60-80°C) in soxhlet apparatus. The marc
was dried and successively extracted with
methanol. The methanolic extract (1.34% yield)
was concentrated under vaccum below 40°C.
It was extracted successively with toluene and
ethylacetate (1:1) by column chromatography
(0.26% yield). This fraction was used for study.
2.2 Animals
Albino mice (22-25g) were obtained from
Serum Institute, Pune. Animals were housed
into groups of five at an ambient temp of
25±1°C. Animals had free access to food
(Hindustan Lever, India) and water. Animals
were deprived of food but not water 4 h before
the experiment. The Institutional Animal Ethical
Committee approved the protocol of this study.
2.3 Drugs and chemicals:
Piracetam (Pirament-IPCA) and Scopolamine
(Buscopan-German Remedies) were used for
the study. The drugs and extract were dissolved
in water for injection and were administered
intra-peritoneally.
2.4 Behavioral paradigms
2.4.1 Passive Shock Avoidance Paradigm
The method used was essentially the same as
described earlier [10]. Mice were placed
individually on the electric grid and allowed
to explore the maze for 1 min. The stimulus
(20V) with AC current of 5mA was applied and
latency to reach the shock free zone (SFZ) was
recorded 3 consecutive times as a basal
reading. Animals that reach the SFZ in 2 min
in the first trial were selected for the study.
After 1 h of the first trial, each animal was put
on the grid again and the latency to reach the
SFZ and the number of mistakes (descents) the
animal made in 10 min were recorded as
parameters of acquisition and retention
respectively (Day 1). Scopolamine (1 mg/kg)
was injected intra-peritoneally 30 min after
MOE or Piracetam. After 30 min the animals
were placed on the grid and latency to reach
SFZ and the number  of mistakes were counted
for 10 min. The same parameters were noted
on  the next day (Day 2)
2.4.2 Elevated Plus Maze
Mice were placed individually at the end of
open arm facing away from the central platform
and the time it took to move from open arm to
either of the closed arm (Transfer latency, TL)
was recorded [11]. On the first day, the mouse
was allowed to explore the plus maze after the
measurement of transfer latency. TL measured
on the first and second day served as parameters
for acquisition and retrieval respectively. All
the drugs were administered 30 min before the
first trial either alone or in combination.
2.5 Effect on gross behaviour
Mice of either sex were divided into 4 groups
of 6 each. They were administered the extract
at a dose of 50,100, and 200 mg /kg p.o and
observed for gross behavioral changes.  Animals
were observed for activity, grooming,
convulsions, sedation, and hypothermia  for
4 h after the extract was administered.
2.6 Statistical analysis
All values are shown as mean ± SEM. The results
were statistically analyzed using one way
analysis of variance followed by Dunnett’s test.
P values < 0.05 were considered significant.
3. Results and discussion
In passive shock avoidance paradigm MOE
(100 mg/kg) significantly (P<0.05)  reduced the
latency to reach SFZ on Day 1 and the number
of mistakes on both the days. Piracetam (100
mg/kg) significantly reduced the latency to
reach the SFZ and the number of mistakes.
Scopolomine (1mg/kg) significantly increased
the latency to reach the SFZ and the number
of mistakes both on the first and the second
day. Piracetam also antagonized the cognitive
dysfunction induced by Scopolomine. MOE
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(50 mg/kg) antagonized the effects of
Scopolomine.
Additional evidence for the nootropic activity
was obtained from the studies on elevated plus
maze. Scopolomine increased the TL on the
first day. Piracetam significantly shortened the
TL on the first and the second day and also
antagonized the effect of scopolamine. MOE
(50 mg/kg) significantly (P<0.05)
reduced the TL on the second day. It
also antagonized the effect of
Scopolamine .
The present study indicates that the
leaves of Moringa oleifera  possess
nootropic effect in view of its
facilitatory effect on retention and
acquired learning. Despite extensive
research, the neurological basis of
learning and memory remains
controversial.
Although involvement of central
cholinergic system is well
established the role of other
neurotransmitter systems cannot be
ignored. The shortening of TL by
Piracetam as well as MOE indicates
improvement of memory which is in
accordance with the nootropic activity, namely
improvement of memory in accordance with
the hypothesis with Itoh et al  [11].
Both Piracetam and MOE meet the major
criteria for nootropic activity, namely
improvement of memory in absence of
Table 1
Effect of MOE of leaves of Moringa oleifera  on Passive shock avoidance paradigm.
Sl. Treatment    Latency to reach SFZ No of mistakes in 10 min
No. (mg/kg)                 (secs)
Day 1 Day 2 Day 1 Day 2
1 Vehicle 15 ±1.12 11 ± 1.14 12.3 ± 2.66 25.33 ± 0.94
2 Piracetam (100) 8 ± 1* 4.66 ± 0.38 6.5 ± 1.53* 10 ± 1.32*
3 Scopolamine (1) 23.25 ± 0.59 29.5 ± 6.99* 18.75 ± 1.61* 19.75 ± 3.39
4 MOE (50) 11.66 ± 0.72 10.66 ± 0.57 4 ± 0.66* 5 ± 0.12 *
5 MOE (100) 9 ± 0.25* 8 ± 0.66 0.25 ± 0.12* 6.5 ± 1.39 *
6 Piracetam (100) +
Scopolamine (1) 9 ± 1.06* 23.5 ± 5.48 9.5 ± 0.53 9.5 ± 2.29 *
7 MOE (50) +
Scopolamine (1) 10 ± 1.77* 16 ± 2.61 0.25 ± 0.12* 10.33 ± 0.62*
     F 27.34 6.29 24.87 17.71
n = 5, * P < 0.05  ANOVA followed by Dunnett’s test.
Table 2
Effect of MOE of leaves of Moringa oleifera on Transfer
Latency (TL) on Elevated plus maze apparatus
Sl. Treatment       Transfer Latency (TL)
No. (mg/kg)                  (secs)
Day 1 Day 2
1 Vehicle 17.5 ±2.10 9.25 ± 1.62
2 Piracetam (100) 8.25 ± 0.80* 5.5±0.47*
3 Scopolamine (1) 20 ± 4.09 6 ± 0.35
4 MOE (50) 9.66 ± 1.12 4.66 ± 0.52*
5 MOE (100) 11.25±2.63 4.75± 0.24*
6 Piracetam (100) +
Scopolamine (1) 16.5± 1.23 5.5 ± 0.17*
7 MOE (50) +
Scopolamine (1) 9.25± 0.82 7.75 ± 1.38
F 4.79 3.84
n = 5, * P < 0.05  ANOVA followed by Dunnett’s test.
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cognitive deficit [12].
Further investigations using more experimental
paradigms are required for further confirmation
of nootropic actions of leaves of Moringa
oleifera.
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